Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4SANOFI VACCINES CANADA LTD.

02 3GLAXOSMITHKLINE INC

03 2PFIZER CANADA ULC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : SCHEDULE D

Registration Country : Canada

MENINGOCOCCAL GROUP Y POLYSACCHARIDE-TETANUS TOXOID CONJUGATE

Brand Name : MENQUADFI

Dosage Form : SOLUTION

Dosage Strength : 10MCG/0.5ML

Packaging :

Approval Date :

Application Number : 2507161

Regulatory Info : SCHEDULE D

Registration Country : Canada

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : SCHEDULE D

Registration Country : Canada

MENINGOCOCCAL GROUP A POLYSACCHARIDE-TETANUS TOXOID CONJUGATE

Brand Name : MENQUADFI

Dosage Form : SOLUTION

Dosage Strength : 10MCG/0.5ML

Packaging :

Approval Date :

Application Number : 2507161

Regulatory Info : SCHEDULE D

Registration Country : Canada

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : SCHEDULE D

Registration Country : Canada

MENINGOCOCCAL GROUP W POLYSACCHARIDE-TETANUS TOXOID CONJUGATE

Brand Name : MENQUADFI

Dosage Form : SOLUTION

Dosage Strength : 10MCG/0.5ML

Packaging :

Approval Date :

Application Number : 2507161

Regulatory Info : SCHEDULE D

Registration Country : Canada

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : SCHEDULE D

Registration Country : Canada

MENINGOCOCCAL GROUP C POLYSACCHARIDE-TETANUS TOXOID CONJUGATE

Brand Name : MENQUADFI

Dosage Form : SOLUTION

Dosage Strength : 10MCG/0.5ML

Packaging :

Approval Date :

Application Number : 2507161

Regulatory Info : SCHEDULE D

Registration Country : Canada

Sanofi Company Banner

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

MENINGOCOCCAL GROUP A OLIGOSACCHARIDE

Brand Name : MENVEO

Dosage Form : SOLUTION

Dosage Strength : 10MCG/0.5ML

Packaging : 0.5ML

Approval Date :

Application Number : 2347393

Regulatory Info : SCHEDULE D

Registration Country : Canada

blank

06

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

MENINGOCOCCAL GROUP C OLIGOSACCHARIDE

Brand Name : MENVEO

Dosage Form : SOLUTION

Dosage Strength : 5MCG/0.5ML

Packaging : 0.5ML

Approval Date :

Application Number : 2347393

Regulatory Info : SCHEDULE D

Registration Country : Canada

blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

MENINGOCOCCAL GROUP C OLIGOSACCHARIDE

Brand Name : MENJUGATE LIQUID

Dosage Form : SUSPENSION

Dosage Strength : 10MCG/0.5ML

Packaging : 0.5ML

Approval Date :

Application Number : 2440709

Regulatory Info : SCHEDULE D

Registration Country : Canada

blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

MENINGOCOCCAL POLYSACCHARIDE VACCINE GRP C

Brand Name : NEISVAC-C

Dosage Form : SUSPENSION

Dosage Strength : 10MCG/0.5ML

Packaging : 0.5ML/10X0.5ML/20X0.5ML

Approval Date :

Application Number : 2245057

Regulatory Info : SCHEDULE D

Registration Country : Canada

blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C

Brand Name : NIMENRIX

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 5MCG/0.5ML

Packaging : 0.5ML/10X0.5ML

Approval Date :

Application Number : 2402904

Regulatory Info : SCHEDULE D

Registration Country : Canada

blank